🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to support the clinical value of entecavir by ...
Status
Completed
Location
Multiple Locations
Start Date
2009-05
Trial ID
NCT01155427
Switching to Entecavir will result in superior antiviral efficacy as compar...
Status
Completed
Location
Local Institution
Start Date
2008-07
Trial ID
NCT00718887
Treatments Being Tested
The purpose of this study is to evaluate the long-term efficacy and safety ...
Status
Unknown
Location
302 Military Hospital Of China
Start Date
2013-03
Trial ID
NCT01834508
Treatments Being Tested
The primary objectives of this study are to evaluate the safety and efficac...
Status
Completed
Location
Dumont-UCLA Liver Transplant Center
Start Date
2013-09-13
Trial ID
NCT01943799
Treatments Being Tested
This study evaluates whether PegIFN alfa-2a add on can improve CHB patients...
Status
Unknown
Location
Multiple Locations
Start Date
2015-12
Trial ID
NCT02644538
Treatments Being Tested
This 3 arm study will assess the efficacy and safety of PEGASYS alone, or i...
Status
Completed
Location
Changhua Christian Hospital; Internal Medicine
Start Date
2010-05-07
Trial ID
NCT00922207
Treatments Being Tested
This is a phase IIIb comparative study of entecavir 1.0 mg once daily (QD) ...
Status
Completed
Location
Research And Education, Inc.
Start Date
2003-08
Trial ID
NCT00065507
Treatments Being Tested
Entecavir demonstrated superior virologic and biochemical benefits over lam...
Status
Unknown
Location
Shanghai First People's Hospital
Start Date
2009-08
Trial ID
NCT01139203
Treatments Being Tested
The CHB subjects who are cirrhosis, will be randomized to two groups. The ...
Status
Unknown
Location
Nanhua Hospital
Start Date
2017-03-10
Trial ID
NCT03084250
Treatments Being Tested